Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenytoin crossover study in autism spectrum disorder
ACTRN12614000747628Phase 2Recruiting
- Sponsor
- University of Sydney
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of phenytoin in Autism Spectrum Disorder (ASD) (2 arms), sponsored by University of Sydney. Primary endpoints: Eye-gaze Movie Scene Task, Facial emotion recognition and 1 more. Started Apr 2015; status: recruiting.
02
Drugs
phenytoin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ACTRN12614000747628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000747628.